PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,576,762 | -31.2% | 510,279 | +0.2% | 0.00% | 0.0% |
Q2 2023 | $2,292,255 | -21.8% | 509,390 | -1.0% | 0.00% | 0.0% |
Q1 2023 | $2,932,924 | -5.7% | 514,548 | -0.1% | 0.00% | 0.0% |
Q4 2022 | $3,110,425 | -8.3% | 514,971 | +0.3% | 0.00% | 0.0% |
Q3 2022 | $3,393,000 | +35.8% | 513,293 | +7.3% | 0.00% | 0.0% |
Q2 2022 | $2,498,000 | -24.9% | 478,525 | -0.7% | 0.00% | 0.0% |
Q1 2022 | $3,327,000 | -43.0% | 482,119 | +2.8% | 0.00% | -50.0% |
Q4 2021 | $5,837,000 | -60.4% | 468,797 | -0.7% | 0.00% | -50.0% |
Q3 2021 | $14,758,000 | +37.4% | 472,246 | +25.9% | 0.00% | +33.3% |
Q2 2021 | $10,741,000 | -11.8% | 375,166 | +33.4% | 0.00% | -25.0% |
Q1 2021 | $12,183,000 | -40.1% | 281,164 | -1.1% | 0.00% | -42.9% |
Q4 2020 | $20,334,000 | +30.3% | 284,187 | -45.1% | 0.01% | +16.7% |
Q3 2020 | $15,608,000 | – | 518,011 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 10,039,691 | $313,740,000 | 3.45% |
Baker Brothers Advisors | 10,123,824 | $316,370,000 | 1.39% |
Logos Global Management LP | 400,000 | $12,500,000 | 0.90% |
HHLR ADVISORS, LTD. | 583,333 | $18,229,000 | 0.24% |
Rock Springs Capital Management LP | 362,359 | $11,324,000 | 0.24% |
Virtus ETF Advisers LLC | 6,292 | $197,000 | 0.09% |
FEDERATED HERMES, INC. | 408,100 | $12,753,000 | 0.02% |
Virtu Financial LLC | 7,940 | $248,000 | 0.02% |
UBS ASSET MANAGEMENT AMERICAS LLC | 1,483,319 | $46,353,719,000 | 0.02% |
FMR LLC | 7,055,666 | $220,489,000 | 0.02% |